Motion Sickness: Clinical Trials

4 trials for Motion Sickness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Unknown 1

Follow Motion Sickness: new trials by email Literature Review of Motion Sickness trials Research Report on Motion Sickness

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function
First patient Bupivacaine liposome and next patient Bupivacaine liposome - Motion Sickness
Phase 4CompletedAffiliated Hospital of Jiaxing University552025-05-202025-12-29
Gynecologic Endoscopic Surgery of Female Motion Sickness Patients
Ibuprofen, sufentanil - Motion Sickness, Postoperative Nausea and Vomiting
Phase 4CompletedSecond Hospital of Jilin University662022-02-012024-01-31
Meclizine Plasma Levels in Responders and Non-responders
Meclizine Hydrochloride - Seasickness, Meclizine
Phase 4UnknownMedical Corps, Israel Defense Force502020-09-012020-07-23
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
Z. officinale extract - Motion Sickness
Phase 4CompletedFundação Educacional Serra dos Órgãos1842019-01-022019-09-25

Narrower conditions

Postoperative Nausea and Vomiting (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Nausea (1)  ·  Pathologic Processes (1)  ·  Postoperative Complications (1)  ·  Signs and Symptoms, Digestive (1)  ·  Vomiting (1)

Interventions

Ibuprofen (1)  ·  Meclizine (1)  ·  Sufentanil (1)

Sponsors

Affiliated Hospital of Jiaxing University (1)  ·  Fundação Educacional Serra dos Órgãos (1)  ·  Medical Corps, Israel Defense Force (1)  ·  Second Hospital of Jilin University (1)

Countries

China (2)  ·  Brazil (1)

Top investigators

Qinghe Zhou (1)